Israel | White & Case
Israeli Law

Israel

We advise on transactions across a broad range of industries in Israel, including high-tech, healthcare and medical devices, cleantech, agriculture, real estate, energy and oil and gas, chemicals, consumer products and financial services. Our work covers capital markets, mergers and acquisitions, private equity, venture capital, banking and leveraged finance, intellectual property, project finance and litigation.

White & Case has advised on some of the largest transactions ever to come out of Israel, including advising on the two largest ever Israeli IPOs – the $1.6 billion IPO of Oil Refineries Ltd. (Bazan) and the $1.4 billion IPO of AFI Development.

Over the last decade, we have helped Israeli companies raise over $20 billion in debt financing and Israeli companies and investors in raising over $9 billion in equity financing.

 

AWARDS

Tier 1: Corporate/M&A
Chambers Global, Israel 2014

Joshua Kiernan is ranked: Star individual lawyer for Corporate/M&A: Experts Based Abroad: Israel   Notable practitioner for Capital Markets: Experts Based Abroad: Israel.

"[White & Case's Israel Practice has a] "Very high level of expertise, availability and dedication."
Chambers Global, Israel 2014

"Josh Kiernan maintains his dominant position in the Israeli market. He is renowned for his in-depth expertise on corporate and capital markets transactions involving the country."

Josh is also noted as having a "superb reputation for his capital markets experience in this jurisdiction, and when it comes to advising Israeli clients on cross-border issues, his fans say he is 'very involved and very assertive and pretty much rules.'"

"Clients praise New York-based partner Colin Diamond, who has 'an amazing knowledge of IPOs, and the experience to deal with any problem or issue that comes up.'"

"This team has a firmly established foothold within the Israeli market, and has amassed formidable experience in M&A transactions, financings and capital markets issues."
Chambers Global, Israel 2013

 

US Equity Capital Markets/Issuer's representation
Representation of numerous Israleli companies in connection with their IPOs on NASDAQ and the NYSE, including CyberArk Software, Wix, MediWound, ReWalk Robotics, Neuroderm, Evogene, Enzymotec, Allot Communications, Voltaire, Saifun and Given Imaging.

US Equity Capital Markets/Underwriters' representation
Representation of the underwriters in connection with numerous IPOs on NASDAQ and the NYSE and SEC-registered follow-on and secondary offerings by numerous Israeli companies such as SodaStream, Varonis, Mellanox, Ormat, Lumenis, MediaMind, Foamix, Macrocure, Sapiens, Magic Software, Aladdin Knowledge Systems, Wintegra, Ituran and PowerDsine.

European Equity Capital Markets
Representation of the issuer or underwriters on the London Stock Exchange or AIM IPOs of numerous Israeli-related companies including Matomy Media, Frutarom, AFI Development, Mirland Development, Plaza Centers, Ablon, RGI and Dor Energy.

Mergers & Acquisitions
We advised: Viber on its US$900 million sale to Rakuten; SuperDerivatives on its US$350 million sale to Intercontinental Exchange; Altria on its US$110 million acquisition of Green Smoke; Provigent in its US$335 million sale to Broadcom for $335 million; Strauss Elite in its sale of a 25% stake in Strauss Coffee to TPG for $250 million; and NICE Systems on its US$150 million acquisition of Merced Systems.

Debt Capital Markets
We advised B Communications, the controlling shareholder of Bezeq, on its ground-breaking $800 million Rue 144A/Reg S High Yield Bond offering, the first ever international bond offering listed on the Tel Aviv Stock Exchange; the underwriters on a $217 million high yield bond offering by Alon Refining; Israel Corporation subsidiary Inkia Energy on two high yield bonds aggregating $450 million; the underwriters on a project bond offering for Ormat subsidiary Orcal; Bezeq on its €750 million EMTN programme and €300 million Eurobond offering on the Luxembourg Stock Exchange; underwriters in connection with convertible bond offerings by Makhteshim-Agan and Audiocodes; Israel Chemicals Ltd. on its cross-border private placement of $275 million of senior unsecured notes to institutional investors.

Banking
We advised the lenders on over $13 billion in acquisition and other financings for Teva Pharmaceuticals, the largest company in Israel; GSO Capital, the credit arm of the Blackstone Group, in its recent $1 billion in committed acquisition financing to finance Amaya Gaming Group's $4.9 billion acquisition of Israeli-owned online poker giant Rational Group, creating the world's largest publically traded i-gaming company; advised lenders, arrangers or borrowers in financings for a broad range of other Israeli companies including the Tshuva Group, Park Plaza Hotel Group, Alrov Group (acquisition financings for Café Royal Hotel London and Lutetia Hotel Paris), Avgol Fibers, Netafim and Eurocom.

 

Israel
About

We advise on transactions across a broad range of industries in Israel, including high-tech, healthcare and medical devices, cleantech, agriculture, real estate, energy and oil and gas, chemicals, consumer products and financial services. Our work covers capital markets, mergers and acquisitions, private equity, venture capital, banking and leveraged finance, intellectual property, project finance and litigation.

White & Case has advised on some of the largest transactions ever to come out of Israel, including advising on the two largest ever Israeli IPOs – the $1.6 billion IPO of Oil Refineries Ltd. (Bazan) and the $1.4 billion IPO of AFI Development.

Over the last decade, we have helped Israeli companies raise over $20 billion in debt financing and Israeli companies and investors in raising over $9 billion in equity financing.

 

AWARDS

Tier 1: Corporate/M&A
Chambers Global, Israel 2014

Joshua Kiernan is ranked: Star individual lawyer for Corporate/M&A: Experts Based Abroad: Israel   Notable practitioner for Capital Markets: Experts Based Abroad: Israel.

"[White & Case's Israel Practice has a] "Very high level of expertise, availability and dedication."
Chambers Global, Israel 2014

"Josh Kiernan maintains his dominant position in the Israeli market. He is renowned for his in-depth expertise on corporate and capital markets transactions involving the country."

Josh is also noted as having a "superb reputation for his capital markets experience in this jurisdiction, and when it comes to advising Israeli clients on cross-border issues, his fans say he is 'very involved and very assertive and pretty much rules.'"

"Clients praise New York-based partner Colin Diamond, who has 'an amazing knowledge of IPOs, and the experience to deal with any problem or issue that comes up.'"

"This team has a firmly established foothold within the Israeli market, and has amassed formidable experience in M&A transactions, financings and capital markets issues."
Chambers Global, Israel 2013

 

Experience

US Equity Capital Markets/Issuer's representation
Representation of numerous Israleli companies in connection with their IPOs on NASDAQ and the NYSE, including CyberArk Software, Wix, MediWound, ReWalk Robotics, Neuroderm, Evogene, Enzymotec, Allot Communications, Voltaire, Saifun and Given Imaging.

US Equity Capital Markets/Underwriters' representation
Representation of the underwriters in connection with numerous IPOs on NASDAQ and the NYSE and SEC-registered follow-on and secondary offerings by numerous Israeli companies such as SodaStream, Varonis, Mellanox, Ormat, Lumenis, MediaMind, Foamix, Macrocure, Sapiens, Magic Software, Aladdin Knowledge Systems, Wintegra, Ituran and PowerDsine.

European Equity Capital Markets
Representation of the issuer or underwriters on the London Stock Exchange or AIM IPOs of numerous Israeli-related companies including Matomy Media, Frutarom, AFI Development, Mirland Development, Plaza Centers, Ablon, RGI and Dor Energy.

Mergers & Acquisitions
We advised: Viber on its US$900 million sale to Rakuten; SuperDerivatives on its US$350 million sale to Intercontinental Exchange; Altria on its US$110 million acquisition of Green Smoke; Provigent in its US$335 million sale to Broadcom for $335 million; Strauss Elite in its sale of a 25% stake in Strauss Coffee to TPG for $250 million; and NICE Systems on its US$150 million acquisition of Merced Systems.

Debt Capital Markets
We advised B Communications, the controlling shareholder of Bezeq, on its ground-breaking $800 million Rue 144A/Reg S High Yield Bond offering, the first ever international bond offering listed on the Tel Aviv Stock Exchange; the underwriters on a $217 million high yield bond offering by Alon Refining; Israel Corporation subsidiary Inkia Energy on two high yield bonds aggregating $450 million; the underwriters on a project bond offering for Ormat subsidiary Orcal; Bezeq on its €750 million EMTN programme and €300 million Eurobond offering on the Luxembourg Stock Exchange; underwriters in connection with convertible bond offerings by Makhteshim-Agan and Audiocodes; Israel Chemicals Ltd. on its cross-border private placement of $275 million of senior unsecured notes to institutional investors.

Banking
We advised the lenders on over $13 billion in acquisition and other financings for Teva Pharmaceuticals, the largest company in Israel; GSO Capital, the credit arm of the Blackstone Group, in its recent $1 billion in committed acquisition financing to finance Amaya Gaming Group's $4.9 billion acquisition of Israeli-owned online poker giant Rational Group, creating the world's largest publically traded i-gaming company; advised lenders, arrangers or borrowers in financings for a broad range of other Israeli companies including the Tshuva Group, Park Plaza Hotel Group, Alrov Group (acquisition financings for Café Royal Hotel London and Lutetia Hotel Paris), Avgol Fibers, Netafim and Eurocom.